培美曲塞用于胸膜恶性间皮瘤的再激发治疗：对于一线接受培美曲塞-铂类双联方案初始治疗的部分患者而言，这是一种选择吗？ - Suppr

Suppr

超能文献

Pemetrexed re-challenge in pleural malignant mesothelioma: an option for a subset of patients initially treated with pemetrexed-platinum doublets in the first-line setting?

作者信息

Zalcman G, Bergot E, Lechapt E

出版信息

Lung Cancer. 2011 Apr;72(1):1-2. doi: 10.1016/j.lungcan.2010.12.021. Epub 2011 Jan 28.

DOI:10.1016/j.lungcan.2010.12.021

PMID:21277041

Abstract

摘要

相似文献

Pemetrexed re-challenge in pleural malignant mesothelioma: an option for a subset of patients initially treated with pemetrexed-platinum doublets in the first-line setting?

Lung Cancer. 2011 Apr;72(1):1-2. doi: 10.1016/j.lungcan.2010.12.021. Epub 2011 Jan 28.

Pemetrexed for malignant pleural mesothelioma: Is it a standard second-line therapy?

Asia Pac J Clin Oncol. 2010 Dec;6(4):248-50. doi: 10.1111/j.1743-7563.2010.01362.x.

Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesothelioma.

Lung Cancer. 2011 Apr;72(1):73-7. doi: 10.1016/j.lungcan.2010.12.004. Epub 2011 Jan 8.

Pemetrexed (Alimta) for mesothelioma.

Med Lett Drugs Ther. 2004 Apr 12;46(1180):31-2.

The value of pemetrexed for the treatment of malignant pleural mesothelioma: a comprehensive review.

Anticancer Res. 2013 Sep;33(9):3553-61.

Second-line treatment for malignant pleural mesothelioma.

Cancer Treat Rev. 2010 Feb;36(1):24-32. doi: 10.1016/j.ctrv.2009.09.003. Epub 2009 Oct 29.

Retreatment with pemetrexed-based chemotherapy in malignant pleural mesothelioma (MPM): a second line treatment option.

Lung Cancer. 2008 May;60(2):294-7. doi: 10.1016/j.lungcan.2007.08.031. Epub 2007 Oct 4.

[Medical treatment of malignant pleural mesothelioma. Role of pemetrexed in current treatment].

Rev Pneumol Clin. 2005 Sep;61(4 Pt 2):4S10-3.

Pemetrexed therapy for malignant pleural mesothelioma.

Ann Pharmacother. 2005 Apr;39(4):678-83. doi: 10.1345/aph.1E329. Epub 2005 Mar 8.

Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma.

J Clin Oncol. 2008 Apr 1;26(10):1698-704. doi: 10.1200/JCO.2006.09.9887.

引用本文的文献

Revisiting cutaneous adverse reactions to pemetrexed.

Oncol Lett. 2011 Sep 1;2(5):769-772. doi: 10.3892/ol.2011.352. Epub 2011 Jul 5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Pemetrexed re-challenge in pleural malignant mesothelioma: an option for a subset of patients initially treated with pemetrexed-platinum doublets in the first-line setting?

作者信息

Zalcman G, Bergot E, Lechapt E

出版信息

Lung Cancer. 2011 Apr;72(1):1-2. doi: 10.1016/j.lungcan.2010.12.021. Epub 2011 Jan 28.

DOI:10.1016/j.lungcan.2010.12.021

PMID:21277041

Abstract

摘要

相似文献

Pemetrexed re-challenge in pleural malignant mesothelioma: an option for a subset of patients initially treated with pemetrexed-platinum doublets in the first-line setting?

Lung Cancer. 2011 Apr;72(1):1-2. doi: 10.1016/j.lungcan.2010.12.021. Epub 2011 Jan 28.

Pemetrexed for malignant pleural mesothelioma: Is it a standard second-line therapy?

Asia Pac J Clin Oncol. 2010 Dec;6(4):248-50. doi: 10.1111/j.1743-7563.2010.01362.x.

Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesothelioma.

Lung Cancer. 2011 Apr;72(1):73-7. doi: 10.1016/j.lungcan.2010.12.004. Epub 2011 Jan 8.

Pemetrexed (Alimta) for mesothelioma.

Med Lett Drugs Ther. 2004 Apr 12;46(1180):31-2.

The value of pemetrexed for the treatment of malignant pleural mesothelioma: a comprehensive review.

Anticancer Res. 2013 Sep;33(9):3553-61.

Second-line treatment for malignant pleural mesothelioma.

Cancer Treat Rev. 2010 Feb;36(1):24-32. doi: 10.1016/j.ctrv.2009.09.003. Epub 2009 Oct 29.

Retreatment with pemetrexed-based chemotherapy in malignant pleural mesothelioma (MPM): a second line treatment option.

Lung Cancer. 2008 May;60(2):294-7. doi: 10.1016/j.lungcan.2007.08.031. Epub 2007 Oct 4.

[Medical treatment of malignant pleural mesothelioma. Role of pemetrexed in current treatment].

Rev Pneumol Clin. 2005 Sep;61(4 Pt 2):4S10-3.

Pemetrexed therapy for malignant pleural mesothelioma.

Ann Pharmacother. 2005 Apr;39(4):678-83. doi: 10.1345/aph.1E329. Epub 2005 Mar 8.

Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma.

J Clin Oncol. 2008 Apr 1;26(10):1698-704. doi: 10.1200/JCO.2006.09.9887.

引用本文的文献

Revisiting cutaneous adverse reactions to pemetrexed.

Oncol Lett. 2011 Sep 1;2(5):769-772. doi: 10.3892/ol.2011.352. Epub 2011 Jul 5.